Chris Ashton has become CEO of Etiologics in Oxford, UK. He joins the company from Orchid Bioscience, where he was CEO. Prior to that, he was commercial director of Inpharmatica and, previously, business development and marketing director at Oxford GlycoSciences.
Chris Ashton, David Evjen
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.